Synthesis of new regioselective imidazole-isoxazole hybrids as in vitro antibacterial agents

imidazole-isoxazole hybrids

Authors

  • Sudheer Reddy V Aragen Life Sciences Pvt Ltd, Hyderabad
  • Rajashekar Reddy N Aragen Life Sciences Pvt Ltd, Hyderabad
  • Venkatram Reddy A Aragen Life Sciences Pvt Ltd, Hyderabad
  • Padma M Andhra University College of Engineering
  • Krishnakanth Reddy Lelelti Sai Life Sciences Limited

Keywords:

Imidazole, isoxazole, one-pot synthesis, Antibacterial, Drug development, medicinal chemistry

Abstract

The one-pot synthesis of some novel imidazole-isoxazole hybrids (5a-5n) and their in vitro antibacterial evaluation against Bacillus subtilis and Staphylococcus aureus was described herein. Among all, compounds 5f, 5g, 5i and 5j displayed greater zone of inhibition on Staphylococcus aureus than the standard streptomycin. Besides, compounds 5f, 5g, 5h, 5i, 5j and 5k displayed higher zone of inhibition towards Bacillus subtilis than the standard. Lastly, minimum inhibitory concentration (MIC) studies of active compounds 5f, 5g, 5h, 5i, 5j and 5k showed that the compounds 5i and 5j having lesser MIC values on Staphylococcus aureus and Bacillus subtilis than the standard.

URN:NBN:sciencein.cbl.2022.v9.425

Published

2022-10-14

Issue

Section

Short Communications

How to Cite

Synthesis of new regioselective imidazole-isoxazole hybrids as in vitro antibacterial agents. (2022). Chemical Biology Letters, 9(4), 425. https://pubs.thesciencein.org/journal/index.php/cbl/article/view/425

Similar Articles

1-10 of 113

You may also start an advanced similarity search for this article.